CLINICAL_TRIALS
research
· 2024-06-11
Clinical Trial Update: Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation [NA]
Summary
This ongoing study evaluates whether the level of CD45RC expression on T lymphocytes can serve as a predictive biomarker for acute rejection after kidney transp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Angers | Conditions: End-stage Renal Disease | NA | Status: RECRUITING